Dexcom (DXCM) Current Deferred Revenue (2010 - 2025)
Dexcom's Current Deferred Revenue was $2.9 million in Q3 2025, down 79.1% from $13.9 million a year earlier and down 52.5% from the prior quarter.
Powered by 
Analysis
Dexcom (DXCM) Current Deferred Revenue (2010 - 2025) Analysis & Trends
At the end of FY2024, Current Deferred Revenue at Dexcom came in at $8 million, down 56.5% from FY2023.
- Current Deferred Revenue shows a five-year compound annual growth rate of 36.3% (FY2019 to FY2024).
- In earlier years, Current Deferred Revenue was $18.4 million in FY2023 (+82.2%), $10.1 million in FY2022 (+381.0%), $2.1 million in FY2021 (-4.5%) and $2.2 million in FY2020 (+29.4%).
- The Q3 2025 figure marks the lowest quarterly Current Deferred Revenue since Q3 2022.
- Compared with a year earlier, Current Deferred Revenue has declined for four straight quarters, with growth averaging 3.0% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q4 2022 (growth of 381.0%); the worst was Q3 2025 (a decline of 79.1%).
- Per Business Quant data, DXCM's Current Deferred Revenue in the three quarters before Q3 2025 was $6.1 million (Q2 2025), $7.8 million (Q1 2025) and $8 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn |
| 10 | Dexcom | 32.57 Bn | 22.88 Bn | 830.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 13.90 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Mar 31, 2024 | 16.40 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 10.10 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.80 Mn |
| Mar 31, 2021 | 1.90 Mn |
| Dec 31, 2020 | 2.20 Mn |
API Access
Dexcom Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DXCM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "DXCM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DXCM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();